Literature DB >> 9860371

Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

H C McGill1, C A McMahan.   

Abstract

A multicenter cooperative study, Pathobiological Determinants of Atherosclerosis in Youth, examined the relation of the risk factors for adult coronary artery disease to atherosclerosis in nearly 3,000 persons, aged 15-34 years, who died from accidents, homicides, and suicides and were autopsied in forensic laboratories. Very-low-density lipoprotein (VLDL) plus low-density lipoprotein (LDL) cholesterol levels were positively, and high-density lipoprotein (HDL) cholesterol levels were negatively, associated with both fatty streaks and raised lesions in the aorta and right coronary artery, particularly after age 25. Elevated glycohemoglobin levels were associated with raised lesions throughout the 15-34-year age span. Body mass index was associated with both fatty streaks and raised lesions of the right coronary artery in men but not in women. Smoking was associated with a 3-fold increase in raised lesions of the abdominal aorta in the 25-34-year age group. Women lagged after men in the extent of raised lesions in the right coronary artery by about 5 years, but the effects of risk factors in women, except for adiposity, were similar to those in men. The risk factors for adult coronary artery disease accelerate atherogenesis in the teenage years and their effects are amplified in young adulthood, 20-30 years before coronary artery disease becomes clinically manifest. Long-range prevention of adult coronary artery disease will require control of the risk factors early in life.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860371     DOI: 10.1016/s0002-9149(98)00720-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  58 in total

Review 1.  Cardiovascular disease risk factors: a childhood perspective.

Authors:  Pradeep A Praveen; Ambuj Roy; Dorairaj Prabhakaran
Journal:  Indian J Pediatr       Date:  2012-05-27       Impact factor: 1.967

2.  The heart of the matter: the case for taking childhood obesity seriously.

Authors:  Scott Brown
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

3.  Coronary artery endothelial transcriptome in vivo: identification of endoplasmic reticulum stress and enhanced reactive oxygen species by gene connectivity network analysis.

Authors:  Mete Civelek; Elisabetta Manduchi; Rebecca J Riley; Christian J Stoeckert; Peter F Davies
Journal:  Circ Cardiovasc Genet       Date:  2011-04-14

4.  Cardiovascular consequences of paediatric obesity: Will there be a future epidemic of premature cardiovascular disease?

Authors:  Brian W McCrindle
Journal:  Paediatr Child Health       Date:  2007-03       Impact factor: 2.253

Review 5.  Identification and treatment of metabolic complications in pediatric obesity.

Authors:  Katie Larson Ode; Brigitte I Frohnert; Brandon M Nathan
Journal:  Rev Endocr Metab Disord       Date:  2009-09       Impact factor: 6.514

6.  Childhood obesity and cardiovascular disease.

Authors:  Tracey Bridger
Journal:  Paediatr Child Health       Date:  2009-03       Impact factor: 2.253

Review 7.  The rationale for initiating treatment of hypercholesterolemia in young adulthood.

Authors:  Daniel Steinberg
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

Review 8.  Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

Authors:  Jonathan Wagner; J Steven Leeder
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

9.  The relative atherogenicity of VLDL and LDL is dependent on the topographic site.

Authors:  Eline Van Craeyveld; Frank Jacobs; Yingmei Feng; Leen C J Thomassen; Johan A Martens; Joke Lievens; Jan Snoeys; Bart De Geest
Journal:  J Lipid Res       Date:  2010-01-19       Impact factor: 5.922

Review 10.  Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice.

Authors:  Anthony S Wierzbicki; Adie Viljoen
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.